What is the significance of Jackson Pei Tai's appointment to the Board of Directors?

Mr. Tai's appointment brings a wealth of international financial and executive experience to Eli Lilly's Board. His service on the Audit and Finance Committees, coupled with his background at major financial institutions and global corporations, is expected to enhance the board's oversight and financial governance.

What are Mr. Tai's qualifications for this role?

Mr. Tai has an extensive background in financial services, including serving as Vice Chairman and CEO of DBS Group Holdings and DBS Bank. He also holds or has held non-executive director positions at companies such as MasterCard Incorporated, NYSE Euronext, and Royal Philips NV, demonstrating broad corporate governance experience.

Will Mr. Tai's appointment have an immediate impact on Eli Lilly's strategy?

While the immediate impact is not explicitly detailed, the addition of a director with Mr. Tai's significant financial and international expertise suggests a potential strengthening of strategic oversight and financial planning. His role on the Audit and Finance committees will allow him to directly influence financial reporting and risk management.

When will shareholders have a chance to vote on Mr. Tai's directorship?

Mr. Tai will serve under interim election and is slated to stand for election by Eli Lilly shareholders at the company's annual meeting in May 2013. Note that based on the filing date of October 22, 2013, it is highly probable that the intended annual meeting date was May 2014, not May 2013.

LLY 8-K: Leadership Changes

Summary

Eli Lilly & Company (LLY) announced on October 22, 2013, the election of Jackson Pei Tai to its Board of Directors, effective November 1, 2013. Mr. Tai brings extensive international financial and executive experience, having previously served as vice chairman and chief executive officer of DBS Group Holdings and DBS Bank. His appointment strengthens the board's expertise, particularly in audit and finance, as he will serve on both committees. Investors may find this addition significant as it signals a move to enhance board oversight and leverage Mr. Tai's diverse global experience, which could be beneficial for the company's strategic direction and financial governance. Mr. Tai's background includes leadership roles at major financial institutions and other prominent public companies, suggesting a focus on strengthening financial acumen at the highest level of the organization.

Key Highlights

1Eli Lilly & Company appointed Jackson Pei Tai to its Board of Directors, effective November 1, 2013.
2Mr. Tai will serve on the Audit and Finance Committees of the Board.
3Mr. Tai has significant international financial experience, including prior roles at DBS Group Holdings and DBS Bank.
4He has held executive positions such as Vice Chairman and Chief Executive Officer.
5Mr. Tai is also a non-executive director for several other prominent global companies, including MasterCard Incorporated and NYSE Euronext.
6The appointment is subject to shareholder election at the company's annual meeting in May 2013 (note: this date seems to be an error in the filing and should likely be May 2014 given the filing date).
7The company issued a press release on October 22, 2013, announcing this appointment, which is furnished as an exhibit.

ELI LILLY & Co 8-K Report, Executive Changes (Oct 22, 2013)

Summary

Key Highlights

Frequently Asked Questions